-
1
-
-
0035338328
-
Bacterial fatty-acid biosynthesis: A genomic-driven target for antibacterial drug discovery
-
Payne DJ, Warren PV, Holmes DJ, Ji Y, Lonsdale JT. Bacterial fatty-acid biosynthesis: a genomic-driven target for antibacterial drug discovery. Drug Discov Today 6: 537-544 (2001)
-
(2001)
Drug Discov Today
, vol.6
, pp. 537-544
-
-
Payne, D.J.1
Warren, P.V.2
Holmes, D.J.3
Ji, Y.4
Lonsdale, J.T.5
-
2
-
-
0034804919
-
Lipid biosynthesis as a target for antibacterial agents
-
Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 40: 467-497 (2001)
-
(2001)
Prog Lipid Res
, vol.40
, pp. 467-497
-
-
Heath, R.J.1
White, S.W.2
Rock, C.O.3
-
3
-
-
0034780806
-
Bacterial fatty acid biosynthesis: Targets for antibacterial drug discovery
-
Campbell JW, Cronan Jr JE. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 55: 305-332 (2001)
-
(2001)
Annu Rev Microbiol
, vol.55
, pp. 305-332
-
-
Campbell, J.W.1
Cronan Jr, J.E.2
-
4
-
-
3843101649
-
Evaluation of epigallocatechin gallate and related plant polyphnols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase
-
Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphnols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 279: 30994-31001 (2004)
-
(2004)
J Biol Chem
, vol.279
, pp. 30994-31001
-
-
Zhang, Y.M.1
Rock, C.O.2
-
6
-
-
0032472224
-
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis
-
Rozwarski DA, Grant GA, Barton DHR, Jacobs Jr WR, Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98-102 (1998)
-
(1998)
Science
, vol.279
, pp. 98-102
-
-
Rozwarski, D.A.1
Grant, G.A.2
Barton, D.H.R.3
Jacobs Jr, W.R.4
Sacchettini, J.C.5
-
7
-
-
34548593708
-
-
Zheng CJ, Sohn MJ, Lee S, Hong YS, Kwak JH, Kim WG. Cephalochromin, a FabI-directed antibacterial of microbial origin. Biochem Biophys Res Commun 362: 1107-1112 (2007)
-
Zheng CJ, Sohn MJ, Lee S, Hong YS, Kwak JH, Kim WG. Cephalochromin, a FabI-directed antibacterial of microbial origin. Biochem Biophys Res Commun 362: 1107-1112 (2007)
-
-
-
-
8
-
-
24944448678
-
Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids
-
Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 579: 157-162 (2005)
-
(2005)
FEBS Lett
, vol.579
, pp. 157-162
-
-
Zheng, C.J.1
Yoo, J.S.2
Lee, T.G.3
Cho, H.Y.4
Kim, Y.H.5
Kim, W.G.6
-
9
-
-
33846811742
-
Atromentin and leucomelone, the first Inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae
-
Zheng CJ, Sohn MJ, Kim WG. Atromentin and leucomelone, the first Inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae. J Antibiot 59: 808-812 (2007)
-
(2007)
J Antibiot
, vol.59
, pp. 808-812
-
-
Zheng, C.J.1
Sohn, M.J.2
Kim, W.G.3
-
10
-
-
33744994317
-
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
-
Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R, Parthasarathy G, Tang YS, Cummings R, Ha S, Dorso K, Motyl M, Jayasuriya H, Ondeyka J, Herath K, Zhang C, Hernandez L, Allocco J, Basilio A, Tormo JR, Genilloud O, Vicente F, Pelaez F, Colwell L, Lee SH, Michael B, Felcetto T, Gill C, Silver LL, Hermes JD, Bartizal K, Barrett J, Schmatz D, Becker JW, Cully D, Singh SB. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441: 358-361 (2006)
-
(2006)
Nature
, vol.441
, pp. 358-361
-
-
Wang, J.1
Soisson, S.M.2
Young, K.3
Shoop, W.4
Kodali, S.5
Galgoci, A.6
Painter, R.7
Parthasarathy, G.8
Tang, Y.S.9
Cummings, R.10
Ha, S.11
Dorso, K.12
Motyl, M.13
Jayasuriya, H.14
Ondeyka, J.15
Herath, K.16
Zhang, C.17
Hernandez, L.18
Allocco, J.19
Basilio, A.20
Tormo, J.R.21
Genilloud, O.22
Vicente, F.23
Pelaez, F.24
Colwell, L.25
Lee, S.H.26
Michael, B.27
Felcetto, T.28
Gill, C.29
Silver, L.L.30
Hermes, J.D.31
Bartizal, K.32
Barrett, J.33
Schmatz, D.34
Becker, J.W.35
Cully, D.36
Singh, S.B.37
more..
-
11
-
-
31944450795
-
Discovery of FabH/FabF inhibitors from natural products
-
Young K, Jayasuriya H, Ondeyka J, Herath K, Zhang C, Kodali S, Galgoci A, Painter R, Brown-Driver V, Yamamoto R, Silver LL, Zheng Y, Ventura JI, Sigmund J, Ha S, Basilio A, Vincente F, Tormo JR, Pelaez F, Youngman P, Cully D, Barrett JF, Schmatz D, Singh SB, Wang J. Discovery of FabH/FabF inhibitors from natural products. Antimicrob Agents Chemother 50: 519-526 (2006)
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 519-526
-
-
Young, K.1
Jayasuriya, H.2
Ondeyka, J.3
Herath, K.4
Zhang, C.5
Kodali, S.6
Galgoci, A.7
Painter, R.8
Brown-Driver, V.9
Yamamoto, R.10
Silver, L.L.11
Zheng, Y.12
Ventura, J.I.13
Sigmund, J.14
Ha, S.15
Basilio, A.16
Vincente, F.17
Tormo, J.R.18
Pelaez, F.19
Youngman, P.20
Cully, D.21
Barrett, J.F.22
Schmatz, D.23
Singh, S.B.24
Wang, J.25
more..
-
12
-
-
0024470551
-
The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium
-
Gustafson K, Roman M, Fenical W. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J Am Chem Soc 111: 7519-7524 (1989)
-
(1989)
J Am Chem Soc
, vol.111
, pp. 7519-7524
-
-
Gustafson, K.1
Roman, M.2
Fenical, W.3
-
13
-
-
40549135646
-
-
Lu XL, Xu QZh, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res 22: 342-347 (2008)
-
Lu XL, Xu QZh, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res 22: 342-347 (2008)
-
-
-
-
14
-
-
36348999714
-
Macrolactins O∼R, glycosylated 24-membered lactones from Bacillus sp. AH159-1
-
Zheng CJ, Lee S, Lee CH, Kim WG. Macrolactins O∼R, glycosylated 24-membered lactones from Bacillus sp. AH159-1. J Nat Prod 70: 1632-1635 (2007)
-
(2007)
J Nat Prod
, vol.70
, pp. 1632-1635
-
-
Zheng, C.J.1
Lee, S.2
Lee, C.H.3
Kim, W.G.4
-
15
-
-
0026531601
-
Stereochemistry of the macrolactins
-
Rychnovsky SD, Skalitzky DJ, Pathirana C, Jensen PR, Fenical W. Stereochemistry of the macrolactins. J Am Chem Soc 114: 671-677 (1992)
-
(1992)
J Am Chem Soc
, vol.114
, pp. 671-677
-
-
Rychnovsky, S.D.1
Skalitzky, D.J.2
Pathirana, C.3
Jensen, P.R.4
Fenical, W.5
-
16
-
-
0004968949
-
Neuronal cell protection actvity of macrolactin A produced by Actinomadura sp
-
Kim HH, Kim WG, Ryoo I J, Kim CJ, Suk JE, Han KH, Hwang S, Yoo ID. Neuronal cell protection actvity of macrolactin A produced by Actinomadura sp. J Microbiol Biotechnol 7: 429-34 (1997)
-
(1997)
J Microbiol Biotechnol
, vol.7
, pp. 429-434
-
-
Kim, H.H.1
Kim, W.G.2
Ryoo, I.J.3
Kim, C.J.4
Suk, J.E.5
Han, K.H.6
Hwang, S.7
Yoo, I.D.8
-
17
-
-
0035022073
-
Novel macrolactins as antibiotic lactones from a marine bacterium
-
Nagao T, Adachi K, Sakai M, Nishijima M, Sano H. Novel macrolactins as antibiotic lactones from a marine bacterium. J Antibiot 54: 333-339 (2001)
-
(2001)
J Antibiot
, vol.54
, pp. 333-339
-
-
Nagao, T.1
Adachi, K.2
Sakai, M.3
Nishijima, M.4
Sano, H.5
-
18
-
-
17544374836
-
New macrolactins from a marine Bacillus sp. Sc026
-
Jaruchoktaweechai C, Suwanborirux K, Tanasupawatt S, Kittakoop P, Menasveta P. New macrolactins from a marine Bacillus sp. Sc026. J Nat Prod 63: 984-986 (2000)
-
(2000)
J Nat Prod
, vol.63
, pp. 984-986
-
-
Jaruchoktaweechai, C.1
Suwanborirux, K.2
Tanasupawatt, S.3
Kittakoop, P.4
Menasveta, P.5
-
19
-
-
33746935630
-
-
Yoo JS, Zheng CJ, Lee S, Kwak JH, Kim WG. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg Med Chem Lett 16: 4889-1892 (2006)
-
Yoo JS, Zheng CJ, Lee S, Kwak JH, Kim WG. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg Med Chem Lett 16: 4889-1892 (2006)
-
-
-
-
20
-
-
33646440995
-
7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia
-
Romero-Tabarez M, Jansen R, Sylla M, Lunsdorf H, Haubler S, Santosa DA, Timmis KN, Molinari G. 7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia. Antimicrobial Agents Chemother 50: 1701-1709 (2006)
-
(2006)
Antimicrobial Agents Chemother
, vol.50
, pp. 1701-1709
-
-
Romero-Tabarez, M.1
Jansen, R.2
Sylla, M.3
Lunsdorf, H.4
Haubler, S.5
Santosa, D.A.6
Timmis, K.N.7
Molinari, G.8
-
21
-
-
33744819176
-
Inhibition of Plasmodium falciparum fatty acid biosynthesis: Evaluation of FabG, FabZ, and FabI and drug targets for flavonoids
-
Tasdemir D, Lack G, Brun R, Ruedi P, Scapozza L, Perozzo R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI and drug targets for flavonoids. J Med Chem 49: 3345-3353 (2006)
-
(2006)
J Med Chem
, vol.49
, pp. 3345-3353
-
-
Tasdemir, D.1
Lack, G.2
Brun, R.3
Ruedi, P.4
Scapozza, L.5
Perozzo, R.6
|